Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea
· Delayed Price · Currency is KRW 6,090.00
+30.00 (0.50%)
Last updated: Apr 29, 2026, 2:10 PM KST
Dongwha Pharm.Co.,Ltd Revenue
In the year 2025, Dongwha Pharm.Co.,Ltd had annual revenue of 496.39B KRW with 6.78% growth. Dongwha Pharm.Co.,Ltd had revenue of 123.70B in the quarter ending December 31, 2025, with 2.54% growth.
Revenue
496.39B
Revenue Growth
+6.78%
P/S Ratio
0.34
Revenue / Employee
600.96M
Employees
826
Market Cap
167.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 496.39B | 31.52B | 6.78% |
| Dec 31, 2024 | 464.87B | 103.77B | 28.74% |
| Dec 31, 2023 | 361.11B | 20.68B | 6.08% |
| Dec 31, 2022 | 340.43B | 47.41B | 16.18% |
| Dec 31, 2021 | 293.02B | 20.94B | 7.70% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daihan Pharmaceutical | 208.61B |
| Kyongbo Pharmaceutical | 264.10B |
| Ilsung Is | 64.29B |
| Hana Pharm | 139.33B |
| Whan In Pharm | 255.21B |
| SAMSUNG PHARM. Co., LTD. | 44.29B |
| Samil Pharmaceutical Co.,Ltd | 210.25B |
| JW Lifescience | 257.83B |